分次团注单期扫描CTA用于评估肠系膜缺血
本研究纳入2015年11月至2016年10月连续80例疑似肠系膜缺血患者,分次团注组与多期CTA组各40例,两组年龄和BMI相似,各8例(20%)阳性。分次团注组SMA衰减较低但诊断信心和准确性无差异,无漏诊,平均有效剂量降低42%,轴位图像数减少。
要点
- 分次团注单期CTA诊断肠系膜缺血的信心和准确性均与多期CTA相当,两组均无漏诊。
- 分次团注组平均有效剂量较标准多期方案降低42%,轴位图像数减少。
- 分次团注组SMA衰减低于多期方案,但SMV衰减及肠管、肝、脾强化最佳期相比例无差异。
核心结论
- 分次团注方案评估肠系膜缺血在临床上可行,诊断信心充足且准确,同时减少图像数量和患者辐射暴露。
研究设计与样本
- 研究类型为HIPAA合规、IRB批准的连续患者对照研究,纳入2015年11月至2016年10月间评估肠系膜缺血的患者。
- 共纳入80例:分次团注组40例与多期CTA组40例,2016年4月前采用多期CTA方案,之后采用分次团注单期扫描CTA。
- 由三名委员会认证的阅片者进行客观与主观评估,结果与复合临床参考结局相关。
关键影像表现/征象
- 分次团注组SMA衰减为258.0 ± 67.3 HU,多期组为336.5 ± 97.5 HU,p < 0.001。
- 分次团注组SMV衰减为194.2 ± 52.2 HU,多期组为213.7 ± 58.4 HU,p = 0.14。
- 两组肠管、肝、脾强化最佳期相比例均达94-99%,比例相似。
诊断标准与关键数值
- 两组各40例中均有8/40(20%)肠系膜缺血阳性病例。
- 阅片者对肠系膜血管和肠管缺血的诊断信心无差异,两组均无漏诊肠系膜缺血病例。
- 分次团注组平均有效剂量较标准多期方案降低42%,p < 0.001。
- 多期组需审阅的轴位图像数为437.9 ± 48.7,分次团注组为263.5 ± 31.2,p < 0.001。
临床应用与阅片要点
- 分次团注单期CTA可减少轴位图像审阅数量,同时保持对肠系膜血管和肠管缺血的诊断信心。
- 分次团注方案在降低辐射剂量的同时未出现肠系膜缺血漏诊。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate split-bolus single scan CTA protocol for evaluation of acute mesenteric ischemia.
MATERIALS AND METHODS: In this HIPAA-compliant IRB-approved study, consecutive patients evaluated for mesenteric ischemia between 11/2015 and 10/2016 were included. Patients scanned prior to 4/2016 were scanned with multiphasic CTA protocol and after with split-bolus single scan CTA. Objective and subjective evaluation was performed by three board-certified readers. Findings were correlated to composite clinical reference outcome.
RESULTS: Eighty patients were included: 40 with split-bolus and 40 with multiphasic CTA protocol with similar age (60.3 ± 16.2 years vs. 64.7 ± 17.0 years, p = 0.19) and BMI (28.0 ± 6.7 vs. 27.0 ± 8.7, p = 0.56). SMA attenuation was higher in multiphasic protocol compared to split-bolus protocol (336.5 ± 97.5 HU vs. 258.0 ± 67.3 HU, p < 0.001) with similar SMV attenuation (multiphasic 213.7 ± 58.4 HU vs. split-bolus 194.2 ± 52.2 HU, p = 0.14). Optimal phase of bowel, liver, and spleen enhancement was seen in similar high proportion (94-99%) in both protocols. There were 8/40 (20%) positive cases of mesenteric ischemia in each group. There was no difference in the diagnostic confidence of the readers for evaluation of the mesenteric vessels and bowel ischemia. There were no missed cases of mesenteric ischemia in either group. Mean effective dose was 42% lower in the split-bolus group, p < 0.001. There was a higher number of axial images to review in multiphasic protocol compared to split-bolus protocol (437.9 ± 48.7 vs. 263.5 ± 31.2, p < 0.001).
CONCLUSIONS: The split-bolus protocol for evaluation of mesenteric ischemia is clinically feasible with confident and accurate diagnostic ability, while reducing number of images and decreasing radiation exposure to the patient.
引用
- Jo PC, Cabral FC, Sahin A, et al. Split-bolus single scan CTA for evaluation of mesenteric ischemia. Abdom Radiol (NY). 2018. PMID: 28986677. doi:10.1007/s00261-017-1333-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。